(Q36762806)

16 August 2017

1 reference

title

Anemia correction in malignancy management: threat or opportunity? (English)

1 reference

16 August 2017

author name string

Jennifer F De Los Santos

series ordinal

1

1 reference

16 August 2017

Gillian M Thomas

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

23 March 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

105

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

517-529

1 reference

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Mode of addition of x-ray doses given with different oxygen concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Reduced oxygen enhancement ratio at low doses of ionizing radiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Raising hemoglobin: an opportunity for increasing survival?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Anemia, hypoxia and transfusion in patients with cervix cancer: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

The effect of anaemia on the fraction of hypoxic cells in an experimental tumour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: Effect on progression-free survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Oxygenation predicts radiation response and survival in patients with cervix cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Carbonic anhydrase IX expression and tumor oxygenation status do not correlate at the microregional level in locally advanced cancers of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Tumor hypoxia in pelvic recurrences of cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

HIF-1-mediated activation of telomerase in cervical cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

The role of p53 in hypoxia-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Association of Tumor Angiogenesis With Bone Marrow Micrometastases in Breast Cancer Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Bone marrow micrometastases and markers of angiogenesis in esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Anemia and elevated systemic levels of vascular endothelial growth factor (VEGF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Erythropoietin increases hemoglobin during radiation therapy for cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Low-dose warfarin does not decrease the rate of thrombosis in patients with cervix and vulvo-vaginal cancer treated with chemotherapy, radiation, and erythropoeitin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Thromboembolic events in patients treated with definitive chemotherapy and radiation therapy for invasive cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Breast cancer trial with erythropoietin terminated unexpectedly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.12.037

10.1016/J.YGYNO.2006.12.037

7 January 2021

Identifiers

DOI

1 reference

16 August 2017

1 reference